EG16412A - Crystalline benzenesulfonate salts of sultamicillins - Google Patents

Crystalline benzenesulfonate salts of sultamicillins

Info

Publication number
EG16412A
EG16412A EG249/83A EG24983A EG16412A EG 16412 A EG16412 A EG 16412A EG 249/83 A EG249/83 A EG 249/83A EG 24983 A EG24983 A EG 24983A EG 16412 A EG16412 A EG 16412A
Authority
EG
Egypt
Prior art keywords
sultamicillins
benzenesulfonate salts
crystalline benzenesulfonate
crystalline
salts
Prior art date
Application number
EG249/83A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG16412A publication Critical patent/EG16412A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG249/83A 1982-04-23 1983-04-20 Crystalline benzenesulfonate salts of sultamicillins EG16412A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (1)

Publication Number Publication Date
EG16412A true EG16412A (en) 1989-03-30

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
EG249/83A EG16412A (en) 1982-04-23 1983-04-20 Crystalline benzenesulfonate salts of sultamicillins

Country Status (27)

Country Link
US (1) US4432987A (OSRAM)
EP (1) EP0092968B1 (OSRAM)
JP (1) JPS58201792A (OSRAM)
KR (1) KR860001279B1 (OSRAM)
AU (1) AU536854B2 (OSRAM)
CA (1) CA1187484A (OSRAM)
CS (1) CS235320B2 (OSRAM)
DD (1) DD209632A5 (OSRAM)
DE (1) DE3362502D1 (OSRAM)
DK (1) DK162168C (OSRAM)
EG (1) EG16412A (OSRAM)
ES (1) ES8406075A1 (OSRAM)
FI (1) FI76092C (OSRAM)
GR (1) GR78582B (OSRAM)
HK (1) HK20588A (OSRAM)
HU (1) HU187068B (OSRAM)
IE (1) IE54628B1 (OSRAM)
IL (1) IL68453A (OSRAM)
NO (1) NO156202C (OSRAM)
NZ (1) NZ203988A (OSRAM)
PH (1) PH18035A (OSRAM)
PL (1) PL134978B1 (OSRAM)
PT (1) PT76587B (OSRAM)
SG (1) SG104087G (OSRAM)
SU (1) SU1138030A3 (OSRAM)
YU (1) YU43170B (OSRAM)
ZA (1) ZA832845B (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6621586A (en) * 1985-11-18 1987-06-02 University Of Texas System, The Polychelating agents for image and spectral enhancement (and spectral shift)
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
US6111098A (en) * 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
AU2003261748B2 (en) 2002-08-29 2006-11-23 Taisho Pharmaceutical Co., Ltd. Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
MXPA05010083A (es) * 2003-03-27 2005-11-23 Basilea Pharmaceutica Ag Cefalosporina en forma cristalina.
KR20060108692A (ko) * 2003-10-31 2006-10-18 알자 코포레이션 메트포르민의 개선된 흡수를 위한 조성물 및 제형
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
KR101588466B1 (ko) 2007-08-22 2016-01-25 아스트라제네카 아베 시클로프로필 아미드 유도체
TWI557111B (zh) 2007-10-26 2016-11-11 加州大學董事會 二芳基乙內醯脲類化合物
MX2011008073A (es) * 2009-01-30 2011-11-18 Glaxosmithkline Llc Hidrocloruro de n-{(1-s)-2-amino -1-[(3-fluorofenil)metil]etil}-5- cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2-tiofenocarboxamida cristalino.
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
JP2012532886A (ja) * 2009-07-10 2012-12-20 エボルバ アクチェンゲゼルシャフト ジイン組成物
MX2012009537A (es) * 2010-02-18 2012-08-31 Astrazeneca Ab Formas solidas que comprenden un derivado de ciclopropilamida.
US20110201623A1 (en) 2010-02-18 2011-08-18 Uczynski Michael A Crystalline Form Of A Cyclopropyl Benzamide Derivative
US9518004B2 (en) * 2012-12-03 2016-12-13 Kaneka Corporation Reduced coenzyme Q10 derivative and method for production thereof
ES2699884T3 (es) * 2013-09-05 2019-02-13 Mitsubishi Tanabe Pharma Corp Nuevo compuesto cristalino de arilalquilamina y método para producir el mismo
EP3760618A1 (en) * 2014-10-21 2021-01-06 ARIAD Pharmaceuticals, Inc. Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl]pyrimidine-2,4-diamine
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
CA3011323A1 (en) * 2016-01-22 2017-07-27 Sandoz Ag Crystalline eravacycline bis-hydrochloride
KR102803160B1 (ko) * 2016-07-07 2025-04-30 사이클리온 테라퓨틱스, 인크. sGC 자극제의 고체 형태
EP3703686A4 (en) * 2017-10-30 2021-11-17 Theracaine LLC HYDROPHOBIC ARENE SULFONATE SALTS
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD994822S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD998740S1 (en) 2019-02-13 2023-09-12 Hs Produkt D.O.O. Firearm
USD1077123S1 (en) 2019-02-13 2025-05-27 Hs Produkt D.O.O. Firearm sight
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
EP4291159A1 (en) * 2021-02-15 2023-12-20 Propella Therapeutics, Inc. Abiraterone prodrugs
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
MX2023012156A (es) * 2021-05-14 2023-10-26 Global Blood Therapeutics Inc Formas solidas de un modulador de hemoglobina.
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
CN118679157A (zh) * 2021-12-28 2024-09-20 深圳扬厉医药技术有限公司 四氢环庚吲唑化合物的盐型、晶型
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
ZAA202301171S (en) 2023-04-28 2024-09-25 Hs Produkt D O O Firearm
TW202517651A (zh) * 2023-07-17 2025-05-01 美商庫拉腫瘤技術股份有限公司 Menin抑制劑之晶型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
BE881675A (fr) * 1979-02-13 1980-08-12 Leo Pharm Prod Ltd B-lactames derives de l'acide penicillanique leur preparation et leurs utilisations therapeutiques
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PL241553A1 (en) 1983-11-21
GR78582B (OSRAM) 1984-09-27
NO156202B (no) 1987-05-04
AU536854B2 (en) 1984-05-24
FI76092C (fi) 1988-09-09
SU1138030A3 (ru) 1985-01-30
EP0092968A1 (en) 1983-11-02
IE54628B1 (en) 1989-12-20
EP0092968B1 (en) 1986-03-12
HK20588A (en) 1988-03-25
SG104087G (en) 1988-07-15
NO156202C (no) 1987-08-19
JPH0119395B2 (OSRAM) 1989-04-11
DK162168C (da) 1992-03-02
IE830926L (en) 1983-10-23
IL68453A (en) 1986-08-31
FI831392L (fi) 1983-10-24
DD209632A5 (de) 1984-05-16
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
ES521728A0 (es) 1984-07-01
ZA832845B (en) 1984-11-28
ES8406075A1 (es) 1984-07-01
US4432987A (en) 1984-02-21
IL68453A0 (en) 1983-07-31
FI831392A0 (fi) 1983-04-22
PH18035A (en) 1985-03-06
CS235320B2 (en) 1985-05-15
DK101783A (da) 1983-10-24
PT76587A (en) 1983-05-01
DK101783D0 (da) 1983-02-28
FI76092B (fi) 1988-05-31
DE3362502D1 (en) 1986-04-17
YU90483A (en) 1986-04-30
KR860001279B1 (ko) 1986-09-05
PL134978B1 (en) 1985-09-30
JPS58201792A (ja) 1983-11-24
AU1387183A (en) 1983-11-17
YU43170B (en) 1989-04-30
KR840004437A (ko) 1984-10-15
DK162168B (da) 1991-09-23
CA1187484A (en) 1985-05-21
HU187068B (en) 1985-11-28
PT76587B (en) 1986-02-27

Similar Documents

Publication Publication Date Title
EG16412A (en) Crystalline benzenesulfonate salts of sultamicillins
GB8515980D0 (en) Mixture of salts
YU42767B (en) Process for obtaining crystalline salts of benzothiazin-dioxide
IL70544A (en) Crystalline cephem-acid addition salts and process for their preparation
GB8316168D0 (en) Crystalline gallosilicates
ZA852042B (en) Crystalline ceftazidime salts
PT81274B (en) Process for the preparation of substituted 2-furanylalkoxyalkylcyclimmonium or 5-oxo-2-furanylalkoxyalkycyclimmonium salts
EP0146389A3 (en) Crystalline silicophosphoaluminate
GB8309584D0 (en) Crystalline zincosilicate
PT80999B (en) Process for the preparation of cyclimmonium salts
EP0146388A3 (en) Crystalline silicophosphoaluminate
EP0146390A3 (en) Crystalline silicophosphoaluminate
DE3462139D1 (en) Process for the preparation of hydroxybenzylphosphonium salts
GB8709632D0 (en) Crystalline compounds
ZA849733B (en) Crystalline silicophospholuminate
YU44123B (en) Process for making crystalline natrium cephoperazone
AU553252B2 (en) Crystalline salts of cefodizim
GB2158828B (en) Salts of fosfomycin
KE3785A (en) Crystalline benzenesulfonate salts of sultamicillin
GB8406435D0 (en) Single crystalline dl-cysteine
GB8414046D0 (en) Crystalline salts
GB8709633D0 (en) Crystalline compounds
GB8302317D0 (en) Crystalline form of sodium
ZA843438B (en) Bis-alkylphosphonium salts of n-phosphonomethylglycine
ZA849730B (en) Crystalline silicophosphoaluminate